InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
OXFORD, England, May 18 /PRNewswire/ -- PharmaVentures
Ltd, announced today that it has been engaged by InDex Pharmaceuticals AB to advise and assist in out-licensing its first in class therapeutic, Kappaproct (DIMS 0150), for the treatment of steroid resistant / dependent Inflammatory Bowel Disea...
PharmaTelevision Launches New Premium Content Service
...until 30 September, 2009. Dr Fintan
Walton, CEO of pharmaventures
- the company behind PharmaTelevision - said,
"Tel...e. As well as PTV News, current
programmes include pharmaventures
Business Review; The Regional Report; The
Notes to Editors:
A leading results driven organisation,...
Pfizer - Wyeth: Good Deal – Bad Deal?
...o obvious bar to any merger going ahead.
PharmaVentures ( www.pharmaventures.com ) assists ...on advisory services to the Life Science industry. pharmaventures
is based in Oxford, UK, and employs over 35 people...of clients from start-ups to global corporations. pharmaventures
publishes PharmaDeals Review (ISSN 1756-7874 onlin...
Determining Valuations in Challenging Times
...methodologies available, selected case studies and pharmaventures
consultants' experience in deal making advisory se... fit within the deal?" More case studies - pharmaventures
highlights the issues and pitfalls
Notes to Editors:
PharmaVentures assists pharmaceutical and biotech...
PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
today announces the launch of a brand new internet-based
television show//: pharmaventures
Dr Fintan Walton, CEO, PharmaVentures, says, ‘This s...
Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
OXFORD, England, April 24 /PRNewswire/ -- PharmaVentures
today that it has been engaged by Merck & Co, Inc. to advise and assist in
divesting its world class research centre, the IRBM, located near Rome,
Italy. The engagement will utilise PharmaVentures' pharmaceutical
PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
Ltd, announced today that it provided the Helsinn ... Oxford, UK (PRWEB) June 24, 2009 -- pharmaventures
Ltd, announced today that it provided the Helsinn ...lease?id=259822 .
Dr Fintan Walton, CEO, pharmaventures
commented, "PharmaVentures are delighted to h...